MatriSys Bioscience, Inc. — Form D
MatriSys Bioscience, Inc. of LA JOLLA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-27. The offering totals $61.7M, of which $8.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-07-27
- Form: D
- Accession: 0001940083-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $61.7M
- Amount sold: $8.4M
- Remaining: $53.3M
- Investors: 49
- Date of first sale: 2022-07-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-453924
Issuer
- Name: MatriSys Bioscience, Inc.
- CIK: 0001940083
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 505 COAST BLVD SOUTH, LA JOLLA, CA, 92037
- Phone: 619-633-2864
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Philippe Calais | Director | La Jolla, CA |
| James Mackay | Director | San Diego, CA |
| Magda Marquet | Director | La Jolla, CA |
| Carey Ng | Director | LOS ANGELES, CA |
| Philippe Calais | Executive Officer | La Jolla, CA |
More